Fairvalue-Calculator Fairvalue-Calculator
EN DE

JRSIS Health Care Corporation (JRSS) Fair Value & Analysis

Consumer Cyclical · US · Market cap $2.5M

Price$0.0294
Fair Value$0.0237
Upside-19.4%
Quality84/100
Evidence: Medium

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

JRSIS Health Care Corporation (JRSS) currently trades at $0.0294, while our model-based Fair Value estimate is $0.0237 — implying the stock looks roughly 19.4% overvalued today. We read business quality at 84/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.

Open the full interactive analysis →

Similar stocks

Alimentation Couche-Tard Inc (ANCTF) -23% Casey's General Stores, Inc (CASY) -71% Williams-Sonoma, Inc (WSM) -44% Ulta Beauty, Inc (U1LT34) -21% DICK'S Sporting Goods, Inc (DKS) +32% China Tourism Group (601888) -29%

Frequently asked questions

Is JRSIS Health Care Corporation (JRSS) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0237 versus a price of $0.0294 — about −19% (overvalued). Model-based estimate, not financial advice.
What is the fair value of JRSS?
Our 21-model fair value for JRSIS Health Care Corporation is $0.0237 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0294.
What is the quality score of JRSS?
JRSIS Health Care Corporation has a Quality Score of 84/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.